Amzak Health Investors
Amzak Health is an evergreen venture fund focused on medtech and biotech. The firm invests in first-in-class and best-in-class technologies, supporting private and select public companies across their life cycle. Amzak emphasizes long-term partnerships with management teams, aiming to improve patient care and address unmet medical needs.
Amzak Health Investors
Services
Equity investments in private and select public life science companies
Provides capital through venture investments in private and select public companies; operates as an evergreen fund.
Portfolio lifecycle support and partnership
Ongoing support for portfolio companies throughout their life cycle; works with management teams to achieve clinical, regulatory, and commercial milestones.
Stage-specific strategic and operational expertise
Leverages investing and operating experience to support companies at stages where domain expertise can help achieve value inflection points (early-stage through commercialization; biotech pre-clinical through proof-of-concept).
Domain-specific (medtech and biotech) guidance
Provides sector-specific assessment and oversight focused on improving patient care and addressing unmet medical needs in medtech and biotech.
Equity investments in private and select public life science companies
Provides capital through venture investments in private and select public companies; operates as an evergreen fund.
Portfolio lifecycle support and partnership
Ongoing support for portfolio companies throughout their life cycle; works with management teams to achieve clinical, regulatory, and commercial milestones.
Stage-specific strategic and operational expertise
Leverages investing and operating experience to support companies at stages where domain expertise can help achieve value inflection points (early-stage through commercialization; biotech pre-clinical through proof-of-concept).
Domain-specific (medtech and biotech) guidance
Provides sector-specific assessment and oversight focused on improving patient care and addressing unmet medical needs in medtech and biotech.
Portfolio
Described on the site as developing handheld ultrasound-guided histotripsy technology to treat a range of conditions. Histotripsy is presented as a non-invasive, non-thermal ablation technology. (Headquarters listed in site content as both Halifax, Nova Scotia and Plymouth, Minnesota in different blocks.)
#Medtech
Developed a non-invasive histotripsy system for tumor destruction; initial indication for liver tumors and under study for other tumor types. Headquarters: Redwood City, California.
#Medtech
Medical device company focused on transcervical, uterus-preserving, incisionless technologies; Sonata system is an intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms.
#Medtech
Described on the site as developing handheld ultrasound-guided histotripsy technology to treat a range of conditions. Histotripsy is presented as a non-invasive, non-thermal ablation technology. (Headquarters listed in site content as both Halifax, Nova Scotia and Plymouth, Minnesota in different blocks.)
#Medtech
Developed a non-invasive histotripsy system for tumor destruction; initial indication for liver tumors and under study for other tumor types. Headquarters: Redwood City, California.
#Medtech
Medical device company focused on transcervical, uterus-preserving, incisionless technologies; Sonata system is an intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms.
#Medtech